Methylation, aging, and pediatric acute lymphocytic leukemia

Leukemia

Volumn 17, Issue 11, 2003, Pages 2063-2064

  Garcia Manero, G ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DNA; GUANINE; HISTONE; HOX PROTEIN; ONCOPROTEIN; PROTEIN KINASE; PROTEIN P14; PROTEIN P15; PROTEIN P16; PROTEIN P57; PROTEIN P73; TUMOR SUPPRESSOR PROTEIN; UVOMORULIN;

ACUTE LYMPHOCYTIC LEUKEMIA; AGING; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CHILD; CHILDHOOD LEUKEMIA; CORRELATION ANALYSIS; CPG ISLAND; DISEASE MARKER; DNA METHYLATION; GENE DELETION; GENE INACTIVATION; GENE MUTATION; GENE SILENCING; GENETIC ANALYSIS; HUMAN; IN VITRO STUDY; MALIGNANT TRANSFORMATION; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION;

EID: 0242391934     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403117     Document Type: Article

References (26)

1. Gutierrez M, Siraj A, Bhargava M, Ozbek U, Banavali S, Chauhary M et al. Concurrent methylation of multiple genes in childhood ALL: correlation with phenotype and molecular subgroup. Leukemia (in press).
2. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Genet 2000; 1: 11-19.
3. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
4. Taylor SM, Jones PA. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 1979; 17: 771-779.
5. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980; 20: 85-93.
6. Jones PA, Taylor SM, Mohandas T, Shapiro LJ. Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. Proc Natl Acad Sci USA 1982; 79: 1215-1219.
7. Silverman LR, Demakos EP, Peterson BE, Kornblith AB, Holland JC, Odchimar-Reissig R et al. Randomized controlled trial of azaciticine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 2002; 20: 2429-2440.
8. Wijermans P, Lubbert M, Verhoef G, Bosly A, Ravoet C, Andre M et al. Low-dose 5-aza-2′-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients. J Clin Oncol 2000; 18: 956-962.
9. Shen L, Toyota M, Kondo Y, Obata T, Daniel S, Pierce S et al. Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia. Blood 2003; 101: 4131-4136.
10. Melki JR, Vincent PC, Clark SJ. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 1999; 59: 3730-3740.
11. Toyota M, Kopecky KJ, Toyota MO, Jair KW, Willman CL, Issa JP. Methylation profiling in acute myeloid leukemia. Blood 2001; 97: 2823-2829.
12. Garcia-Manero G, Daniel J, Smith TL, Kornblau SM, Lee MS, Kantarjian HM et al. DNA methylation of multiple promoter-associated CpG Islands in adult acute lymphocytic leukemia. Clin Cancer Res 2002; 8: 2217-2224.
13. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-8686.
14. Garcia-Manero G, Bueso-Ramos C, Daniel J, Williamson J, Kantarjian HM, Issa JP. DNA methylation patterns at relapse in adult acute lymphocytic leukemia. Clin Cancer Res 2002; 8: 1897-1903.
15. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605-615.
16. Arico M, Valsecchi MC, Camitta B, Schrappe M, Chessells J, Baruchel A et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000; 342: 998-1006.
17. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536-540.
18. Issa JP. Aging, DNA methylation and cancer. Crit Rev Oncol Hematol 1999; 32: 31-43.
19. Garcia-Manero G, Jeha S, Daniel J, Williamson J, Albitar M, Kantarjian H et al. Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia. Cancer 2003; 97: 695-702.
20. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.
21. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826.
22. Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ, Baylin SB. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res 1997; 57: 837-841.
23. Shen L, Kondo Y, Issa JP, Garcia-Manero G. Lack of p21(CIP1) DNA methylation in acute lymphocytic leukemia. Blood 2002; 100: 3432-3433.
24. Martins J, Garcia-Manero G, Daniel J, Kantarjian HM, Issa JP. 06-methylguanine-DNA-methyltransferase (MGMT) is infrequently methylated in acute lymphocytic leukemia. Blood 2001; 98: 180b.
25. Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, Allis CD et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell 2002; 10: 1107-1117.
26. Kouzarides T. Histone methylation in transcriptional control. Curr Opin Genet Dev 2002; 12: 198-209.